3-Thiophenamine, tetrahydro-, 1,1-dioxide → HCID 89793628, compound
Reaction equation
CCN(C(C)C)C(C)C.F[C:11]1[C:12]([CH3:31])=[N:13][C:14]2[C:19]([N:20]=1)=[C:18]([C:21]1[NH:29][C:28]3[CH2:27][CH2:26][NH:25][C:24](=[O:30])[C:23]=3[CH:22]=1)[CH:17]=[CH:16][CH:15]=2.[NH2:32][CH:33]1[CH2:37][CH2:36][S:35](=[O:39])(=[O:38])[CH2:34]1>CS(C)=O>[O:38]=[S:35]1(=[O:39])[CH2:36][CH2:37][CH:33]([NH:32][C:11]2[C:12]([CH3:31])=[N:13][C:14]3[C:19]([N:20]=2)=[C:18]([C:21]2[NH:29][C:28]4[CH2:27][CH2:26][NH:25][C:24](=[O:30])[C:23]=4[CH:22]=2)[CH:17]=[CH:16][CH:15]=3)[CH2:34]1Participants
Conditions
- Temperature
- 80 °C
Procedure
Prepared according to Example 127, using DIPEA (141 μl, 0.803 mmol), 2-(3-fluoro-2-methylquinoxalin-5-yl)-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one (Example 126; 40 mg, 0.135 mmol), (±) 3-amino-tetrahydrothiophene 1,1-dioxide (54.7 mg, 0.405 mmol, Sigma Aldrich), and DMSO (1.4 mL) and stirring at 80° C. for 2 h. Purification by high throughput parallel purification (Rilas Technologies, Woburn, Mass.) provided 2-(3-(((±)-1,1-dioxidotetrahydro-3-thiophenyl)amino)-2-methyl-5-quinoxalinyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one. 1H NMR (DMSO-d6) δ: 11.52-11.67 (m, 1H), 7.80-7.88 (m, 1H), 7.59-7.69 (m, 1H), 7.34-7.41 (m, 1H), 7.25-7.33 (m, 1H), 6.98-7.07 (m, 1H), 6.85-6.98 (m, 1H), 4.91-5.02 (m, 1H), 3.61-3.72 (m, 2H), 3.39-3.49 (m, 3H), 3.21-3.28 (m, 1H), 2.87-2.97 (m, 2H), 2.65-2.74 (m, 1H), 2.55-2.60 (m, 3H), 2.25-2.40 (m, 1H). m/z (ESI, +ve) 412.1 (M+H)+.
Workup
- customPrepared
- customPurification by
- customhigh throughput parallel purification (Rilas Technologies, Woburn, Mass.)
Sources & evidence
- ORD record
- ord-80ff2640a2894f9fb3154fcc8020cc30
- Source dataset
- uspto-grants-2016_07
- Patent number
- US09394297B2
Reaction notes
Loading…